Timing of elective surgery and risk assessment after SARS‐CoV‐2 infection: 2023 update: A multidisciplinary consensus statement on behalf of the Association of Anaesthetists, Federation of Surgical Specialty Associations, Royal College of Anaesthetists and Royal College of Surgeons of England
Recommendations
As issued by the authors
Patients developing SARS-CoV-2 symptoms within 7 weeks of planned surgery, including on the day of surgery, should be screened for SARS-CoV-2.
Elective surgery should not usually be undertaken within 2 weeks of diagnosis of SARS-CoV-2 infection.
Recovered patients who are low risk or having low-risk surgery: most elective surgery can proceed 2 weeks after a SARS-CoV-2 positive test.
Patients not low risk or having other than low-risk surgery 2–7 weeks after infection: individual risk assessment (patient, infection and surgical factors) must be performed, using an objective validated risk prediction tool and shared decision-making.
Surgery should usually proceed unless the risk of proceeding exceeds the risk of delay.
No evidence supports delaying surgery beyond 7 weeks after full recovery from or mild SARS-CoV-2 infection.
Original publication
Composed by AI from the published abstract and checked against it. How Briefs are made →